| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.008 | 0.9 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.024 | 0.9 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.9 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |